FDG PET-CT
FDG PET-CT is a radiation therapy with 17 clinical trials. Currently 3 active trials ongoing. Historical success rate of 92.3%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
85.7%
12 of 14 finished
14.3%
2 ended early
3
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
FDG PET/CT in Lung Cancer Staging
Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT
FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis
Intensive Cancer Screening After Cryptogenic Stroke
Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy
Clinical Trials (17)
FDG PET/CT in Lung Cancer Staging
Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT
FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis
Intensive Cancer Screening After Cryptogenic Stroke
Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy
Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET
Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT
Use of FDG PET/CT to Evaluate Crohn Disease
PET-FDG in Myocarditis
FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With Immunotherapy
Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT
Cold Induced Futile Cycles In White Adipose Tissue
Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer
Imaging NSCLC Treatment Response to Immunotherapy
NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer
Diagnostic Accuracy of FDG PET/CT of Cranial Arteries in GCA
Circadian Brown Adipose Tissue Metabolism
All 17 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 17